Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis.
Article Details
- CitationCopy to clipboard
Cruz MP
Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis.
P T. 2018 Jan;43(1):25-28.
- PubMed ID
- 29290672 [ View in PubMed]
- Abstract
Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis.
DrugBank Data that Cites this Article
- Drugs